Trial Profile
An Open-Label, Randomized, Cross-Over Study to Evaluate the Dose Response of Synbitide HFA MDI in Asthma Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2015
Price :
$35
*
At a glance
- Drugs Budesonide/procaterol (Primary) ; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Intech Biopharm
- 02 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 24 Jun 2014 New trial record